Clinical trial · Interventional
Effect of Infrared-Assisted Intravenous Catheterization on Patient Comfort and Nurse-Patient Trust in Lung Cancer Patients
Effect of Infrared-Assisted Intravenous Catheterization on Patient Comfort and Nurse-Patient Trust in Lung Cancer Patients: A Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260926-000001
Summary
Brief summary (as posted)
This randomized controlled trial evaluated the effect of near-infrared (NIR) vein visualization-assisted peripheral intravenous catheterization on procedure-specific patient comfort, procedural pain and patient trust in nurses in adults with lung cancer receiving outpatient chemotherapy. Patients receiving chemotherapy often develop progressive venous damage, which can make peripheral intravenous catheterization difficult. Failed attempts may increase pain and discomfort and may affect the patient's trust in the nurse. The study used an explanatory sequential mixed-methods design (QUAN→qual). In the quantitative phase, 160 patients were randomized 1:1 to NIR-assisted catheterization or to standard catheterization based on visual inspection and palpation. In the qualitative phase, semi-structured individual interviews were conducted with 11 patients from the intervention group to explore their experiences with the NIR device. The study was conducted at the Outpatient Chemotherapy Unit of Ataturk University Research Hospital, Erzurum, Turkey, as part of a doctoral thesis in Fundamentals of Nursing.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer (Diagnosis) | Malignant Lung Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Near-infrared vein visualization-assisted catheterization | Device | — | UNRESOLVED |
| Routine Catheterization | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- NIR-Assisted Catheterization Group
- description
- Participants (n=80 randomized) received peripheral intravenous catheterization assisted by a near-infrared (NIR) vein visualization device. After tourniquet application and skin antisepsis, the device was held about 20-30 cm above the insertion site and the vein map projected onto the skin was used to select the vein; the device remained active during catheter advancement. Procedures were performed by the trained unit nurses (7 nurses in routine rotation, all with the same device training and a run-in period). Maximum 3 attempts allowed.
- interventionNames
- Device: Near-infrared vein visualization-assisted catheterization
- type
- ACTIVE_COMPARATOR
- label
- Standard Catheterization Group
- description
- Participants (n=80 randomized) received peripheral intravenous catheterization using the unit's routine method of visual inspection and palpation, without any technological assistance (no NIR, ultrasound or transillumination). The same standard procedure and consumables as in the experimental group were used. Procedures were performed by the same trained unit nurses as in the experimental group (patient-level randomization). Maximum 3 attempts allowed.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Aged 18 years or older * Histopathologically confirmed lung cancer (small cell or non-small cell) * Receiving active systemic chemotherapy (at least one cycle completed) * Indication for a peripheral intravenous catheter for chemotherapy administration * Able to speak and understand Turkish sufficiently to communicate * Read and signed the informed consent form Exclusion Criteria: * Situations requiring emergency or life-saving catheterization * Presence of a central venous catheter (port, PICC or tunneled catheter) * Anatomical anomaly, amputation, post-mastectomy lymphedema or arteriovenous fistula in both upper extremities * Active local infection, dermatitis or impaired skin integrity at the planned catheterization site * Altered consciousness or disorientation * Mediastinal, supraclavicular or infraclavicular mass/lymphadenopathy that may affect upper extremity venous return Withdrawal Criteria: * Withdrawal of consent at any stage * Need for an off-protocol intervention (decision for central access after failure at the third attempt) * Development of an acute clinical condition preventing completion of data collection
References
Publications (0)
Data not yet available